To The Moon

$CALIDI BIOTHERAPEUTICS INC(CLDI)$ 

🔺🅱🆄🅻🅻🅸🆂🅷 🔺

🅿🅾🆂🅸🆃🅸🅾🅽🆂 🅾🅿🅴🅽🅴🅳

The CEO will be on Bloomberg this weekend 

CLDI - weekly chart 🎯 Target for this chart is 🎯$1.40

2nd target of 🎯$3.00

Targeting the 13EMA weekly and then the magnet of the 50SMA. Huge divergence on MACD that is bullish!

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California.

We have engaged Ladenberg Thalmann & Co., Inc., or the placement agent, to act as our exclusive placement agent in connection with this offering. The placement agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus supplement and accompanying prospectus. The placement agent has no obligation to buy any of the securities we are offering and the placement agent is not required to arrange the purchase or sale of any specific number or dollar amount of securities. We have agreed to pay to the placement agent the placement agent fees set forth in the table below, which assumes that we sell all of the securities offered by this prospectus supplement. Since we will deliver the securities to be issued in this offering upon our receipt of investor funds, there is no arrangement for funds to be received in escrow, trust or similar arrangement. There is no minimum offering requirement as a condition of closing of this offering. Further, any proceeds from the sale of securities offered by us will be available for our immediate use, despite uncertainty about whether we would be able to use such funds to effectively implement our business plan. See the section entitled “Risk Factors” for more information. We will bear all costs associated with the offering. See “Plan of Distribution” beginning on page of S-15 this prospectus for more information regarding these arrangements.

@Tiger_comments @Daily_Discussion @TigerPicks @TigerStars @TigerObserver @TigerWire@TigerPM